Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 11:09 AM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
NCT ID:
NCT05758012
Eligibility Criteria:
Inclusion Criteria:
* Normal singleton pregnancy at gestational age of 36 weeks or more.
* Women with common comorbid diagnoses (diabetes, hypothyroidism, hypertension)
* pregnancy after in vitro fertilization
Exclusion Criteria:
* placenta praevia or invasive placenta.
* pre-eclampsia.
* Bleeding disorder, such as von Willebrand disease type I.
* Current treatment with low-molecular-weight heparin or other anticoagulation medication (not including aspirin).
* Any known intolerance to either of the study drugs.
* Prolonged QT-time.
* Other serious cardiac disease.
* Liver or kidney failure.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
16 Years
Maximum Age:
40 Years
Study:
NCT05758012
Study Brief:
Protocol Section:
NCT05758012